Rock Springs Capital Management LP - 31 Mar 2025 SCHEDULE 13G/A Report for Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share (TVTX)

Filing Manager
Rock Springs Capital Management LP
Reporting Manager
Rock Springs Capital Management LP
Security
Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
TVTX
Shares outstanding
88,521,091 shares
Disclosed Ownership
2,921,196 shares
Ownership
3.3%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 10:47:34 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Rock Springs Capital Management LP disclosed 3.3% ownership in Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share (TVTX) on 31 Mar 2025."

Quick Takeaways

  • Rock Springs Capital Management LP filed SCHEDULE 13G/A for Travere Therapeutics, Inc. Common Stock, par value $0.0001 per share (TVTX).
  • Disclosed ownership: 3.3%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 15 May 2025, 10:47.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rock Springs Capital Management LP 3.3% 2,921,196 0 2,921,196 /s/ Mark Bussard Mark Bussard - Member
Rock Springs Capital LLC 3.3% 2,921,196 0 2,921,196 /s/ Mark Bussard Mark Bussard - Member
Rock Springs Capital Master Fund LP 2.6% 2,327,521 0 2,327,521 /s/ Mark Bussard Mark Bussard - Member
Mark Bussard 3.3% 2,921,196 0 2,921,196 /s/ Mark Bussard Mark Bussard
Kris Jenner 3.3% 2,921,196 0 2,921,196 /s/ Kris Jenner Kris Jenner

Sponsored